REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Giczamed S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Giczamed S.A. Profile Updated: April 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Giczamed S.A. is a company based in Ecuador, with its head office in Santo Domingo. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on June 10, 2020. It currently has a total number of 7 (2023) employees. There was a net sales revenue increase of 5.26% reported in Giczamed S.A.’s latest financial highlights for 2023. Its total assets grew by 34.52% over the same period. The net profit margin of Giczamed S.A. increased by 3.57% in 2023.

Headquarters
Av. Patricio Romero Valveris 4, Casa Bldg. , Floor 1
Santo Domingo; Santo Domingo de los Tsachilas;

Contact Details: Purchase the Giczamed S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Giczamed S.A. report to view the information.
Outstanding Shares:
Purchase the Giczamed S.A. report to view the information.
Registered Capital:
Purchase the Giczamed S.A. report to view the information.
Incorporation Date:
June 10, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
52.5%
Purchase this report to view the information.
47.5%
Company Performance
Financial values in the chart are available after Giczamed S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.26%▲
Total operating revenue
5.26%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
62.67%▲
Total assets
34.52%▲
Total equity
25.01%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
3.57%▲
Return on Equity (ROE)
10.41%▲
Debt to Equity Ratio
-59.63%▼
Quick Ratio
0.06%▲
Cash Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo